Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 Studies

2013459 citationsReview

Authors

Martin K. Gelbard · Urology Associates

Irwin Goldstein · University of California, San Diego

Wayne J.G. Hellstrom · Tulane University

Chris G. McMahon · University of Sydney

Abstract

IMPRESS I and II support the clinical efficacy and safety of collagenase C. histolyticum for the physical and psychological aspects of Peyronie disease.

Topics & Keywords

Dupuytren's Contracture and Treatments Sexual function and dysfunction studies Genital Health and Disease

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Journal of Urology

Volume 190, Issue 1, pp. 199-207

DOI: 10.1016/j.juro.2013.01.087

Field-Weighted Citation Impact: 28.52